Therapeutic administration of the chemokine CXCL1/KC abrogates autoimmune inflammatory heart disease.
Myocarditis, often due to an aberrant immune response to infection, is a major cause of dilated cardiomyopathy. Microbial pattern recognition receptors, such as TLRs, orchestrate the cytokine and chemokine responses that augment or limit the severity of myocarditis. Using the mouse model of experime...
Saved in:
| Main Authors: | Kurt Bachmaier, Sophie Toya, Asrar B Malik |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089647&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atherosclerotic Plaque Stability Is Affected by the Chemokine CXCL10 in Both Mice and Humans
by: Dolf Segers, et al.
Published: (2011-01-01) -
Pro-inflammatory mediator and cancer-associated chemokine CXCL8 as a prognostic indicator of tumor aggressiveness, angiogenesis, and disease progression with focus on therapeutic implications and recurrence monitoring
by: Hema Shree K, et al.
Published: (2025-03-01) -
KC-bitopological spaces
by: Hamza Qoqazeh, et al.
Published: (2024-11-01) -
Disease modification and symptom relief in osteoarthritis using a mutated GCP‐2/CXCL6 chemokine
by: Sara Caxaria, et al.
Published: (2022-12-01) -
Chemokine CXCL16 Expression Suppresses Migration and Invasiveness and Induces Apoptosis in Breast Cancer Cells
by: Yeying Fang, et al.
Published: (2014-01-01)